223 related articles for article (PubMed ID: 18842592)
21. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
22. Hydrodynamic and functional analysis of HIV-1 Vif oligomerization.
Techtmann SM; Ghirlando R; Kao S; Strebel K; Maynard EL
Biochemistry; 2012 Mar; 51(10):2078-86. PubMed ID: 22369580
[TBL] [Abstract][Full Text] [Related]
23. Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation.
Ma L; Zhang Z; Liu Z; Pan Q; Wang J; Li X; Guo F; Liang C; Hu L; Zhou J; Cen S
Sci Rep; 2018 May; 8(1):8067. PubMed ID: 29795228
[TBL] [Abstract][Full Text] [Related]
24. Dissecting APOBEC3G substrate specificity by nucleoside analog interference.
Rausch JW; Chelico L; Goodman MF; Le Grice SF
J Biol Chem; 2009 Mar; 284(11):7047-58. PubMed ID: 19136562
[TBL] [Abstract][Full Text] [Related]
25. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
26. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
Mehle A; Wilson H; Zhang C; Brazier AJ; McPike M; Pery E; Gabuzda D
J Virol; 2007 Dec; 81(23):13235-41. PubMed ID: 17898068
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.
Mercenne G; Bernacchi S; Richer D; Bec G; Henriet S; Paillart JC; Marquet R
Nucleic Acids Res; 2010 Jan; 38(2):633-46. PubMed ID: 19910370
[TBL] [Abstract][Full Text] [Related]
28. Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F.
Yamashita T; Kamada K; Hatcho K; Adachi A; Nomaguchi M
Microbes Infect; 2008; 10(10-11):1142-9. PubMed ID: 18603011
[TBL] [Abstract][Full Text] [Related]
29. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
30. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Chen KM; Harjes E; Gross PJ; Fahmy A; Lu Y; Shindo K; Harris RS; Matsuo H
Nature; 2008 Mar; 452(7183):116-9. PubMed ID: 18288108
[TBL] [Abstract][Full Text] [Related]
31. [HIV Restriction Factor APOBEC3G and Prospects for Its Use in Gene Therapy for HIV].
Tikhonov AS; Mintaev RR; Glazkova DV; Bogoslovskaya EV; Shipulin GA
Mol Biol (Mosk); 2022; 56(4):546-556. PubMed ID: 35964311
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.
Wang SM; Wang CT
Virology; 2009 May; 388(1):112-20. PubMed ID: 19345973
[TBL] [Abstract][Full Text] [Related]
33. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.
Li XY; Guo F; Zhang L; Kleiman L; Cen S
J Biol Chem; 2007 Nov; 282(44):32065-74. PubMed ID: 17855362
[TBL] [Abstract][Full Text] [Related]
34. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.
Sadler HA; Stenglein MD; Harris RS; Mansky LM
J Virol; 2010 Jul; 84(14):7396-404. PubMed ID: 20463080
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
36. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3G is degraded by the proteasomal pathway in a Vif-dependent manner without being polyubiquitylated.
Dang Y; Siew LM; Zheng YH
J Biol Chem; 2008 May; 283(19):13124-31. PubMed ID: 18326044
[TBL] [Abstract][Full Text] [Related]
38. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
39. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
40. Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3G.
Harjes S; Solomon WC; Li M; Chen KM; Harjes E; Harris RS; Matsuo H
J Virol; 2013 Jun; 87(12):7008-14. PubMed ID: 23596292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
